VIEMED HEALTHCARE, INC.·4

Jun 26, 4:06 PM ET

Frazier William 4

Research Summary

AI-generated summary

Updated

Viemed (VMD) CMO William Frazier Exercises Options, Sells 10,000 Shares

What Happened

  • William Frazier, Chief Medical Officer and Director of Viemed Healthcare (VMD), exercised stock options and sold shares on June 25, 2026. He exercised 10,000 options at $1.81 per share (total exercise cost $18,100) and sold 10,000 shares in an open-market transaction at $11.72 per share (gross proceeds $117,200). The filing also lists a 10,000-share derivative disposition at $0.00 (see Key Details).
  • Approximate pre-tax profit from the exercised-and-sold shares is $117,200 − $18,100 = ~$99,100 (does not account for commissions, taxes, or withholding).

Key Details

  • Transaction date: 2026-06-25; Form 4 filed 2026-06-26 (timely filing).
  • Exercise: 10,000 options at $1.81/share (total $18,100).
  • Sale: 10,000 shares sold at $11.72/share (total $117,200).
  • Additional line in filing: 10,000-share derivative disposition reported at $0.00 (filing does not further explain this entry).
  • Footnote F1: Options were granted to the reporting person on January 4, 2018, and are fully vested.
  • Shares owned after the transaction: not specified in the provided filing details.

Context

  • The sequence (exercise then immediate sale same day) is consistent with a cashless exercise where an insider exercises options and promptly sells shares to capture gains or cover exercise/tax obligations. This is common and not necessarily a directional vote on company prospects.
  • The filing is timely (filed one day after the reported transactions). No 10b5-1 plan, tax-withholding or other special instructions were noted in the provided details.